bisoprolol has been researched along with Peripheral Arterial Disease in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soga, Y | 1 |
| Iida, O | 1 |
| Suzuki, K | 1 |
| Hirano, K | 1 |
| Kawasaki, D | 1 |
| Shintani, Y | 1 |
| Suematsu, N | 1 |
| Yamaoka, T | 1 |
| Tsuchiya, T | 1 |
| Miyashita, Y | 1 |
| Okazaki, S | 1 |
| Shinozaki, N | 1 |
| Takahashi, H | 1 |
1 other study available for bisoprolol and Peripheral Arterial Disease
| Article | Year |
|---|---|
Clinical impact of bisoprolol versus carvedilol in patients undergoing femoropopliteal stenting.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Female; Femoral Ar | 2014 |